Radiopaque TACE System for Hepatocellular Carcinoma

Inherently radiopaque, biodegradable, cost-effective transarterial chemoembolization (TACE) system with liver regeneration potential.

Development of an inherently radiopaque, biodegradable, and cost-effective TACE system with liver regeneration potential for the treatment of hepatocellular carcinoma.

RUSA funded project pursued at the Regenerative Biomaterials and Theranostics Laboratory, CUSAT.